Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation: Meta-Analysis [Clinical Sciences]
Conclusions—
Our findings suggest that standard-dose NOACs were more effective and safer in Asians than in non-Asians, whereas low-dose NOACs performed similarly in both populations.
Source: Stroke - Category: Neurology Authors: Wang, K.-L., Lip, G. Y. H., Lin, S.-J., Chiang, C.-E. Tags: Other anticoagulants, Anticoagulants Clinical Sciences Source Type: research
More News: Atrial Fibrillation | Bleeding | Clinical Trials | Gastroenterology | Hemorrhagic Stroke | Ischemic Stroke | Neurology | Stroke | Vitamin K | Vitamins